These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 40380)

  • 1. Comparative potency and speed of onset of fazadinium and d-tubocurarine.
    Hussain SZ; Healy TE; Birmingham AT
    Acta Anaesthesiol Scand; 1979 Aug; 23(4):331-5. PubMed ID: 40380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of speed of onset of fazadinium, pancuronium, tubocurarine and suxamethonium.
    Blackburn CL; Morgan M
    Br J Anaesth; 1978 Apr; 50(4):361-4. PubMed ID: 26369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on fazadinium bromide (ah 8165): a new non-depolarizing neuromuscular blocking agent.
    Hughes R; Payne JP; Sugai N
    Can Anaesth Soc J; 1976 Jan; 23(1):36-47. PubMed ID: 2378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking potency of fazadinium in man.
    Hashimoto Y; Shima T; Matsukawa S; Satou M
    Anaesthesia; 1979 Jan; 34(1):10-3. PubMed ID: 34334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of fazadinium.
    Bevan DR; D'Souza J; Rouse JM; Caldwell J; Smith RL
    Anaesthesia; 1980 Sep; 35(9):873-8. PubMed ID: 6108730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man.
    Gibaldi M; Levy G; Hayton W
    Anesthesiology; 1972 Mar; 36(3):213-8. PubMed ID: 5011414
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of single twitch and train-of-four responses and of tetanic fade in relation to plasma concentrations of fazadinium in man.
    d'Hollander AA; Duvaldestin P; Delcroix C; Nevelsteen M; Desmonts JM
    Anesth Analg; 1982 Mar; 61(3):225-30. PubMed ID: 6121521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Anesth Analg; 1990 Jul; 71(1):55-9. PubMed ID: 2363529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.
    Bevan DR; D'Souza JD; Rouse JM; Caldwell J; Smith RL
    Eur J Clin Pharmacol; 1981; 20(4):293-8. PubMed ID: 6118278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of priming with fazadinium].
    González Miranda F; Sáez Elegido B; Alvarez López JC
    Rev Esp Anestesiol Reanim; 1987; 34(6):428-30. PubMed ID: 2892234
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
    Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
    Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiopentone and fazadinium crash induction. A comparison with thiopentone and pancuronium.
    Barr AM; Thornley BA
    Anaesthesia; 1980 Feb; 35(2):164-8. PubMed ID: 6104453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents.
    Cashman JN; Jones RM; Vella LM
    Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.
    Tyers MB
    Br J Pharmacol; 1978 Jun; 63(2):287-93. PubMed ID: 27272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blocking activity of tubocurarine in patients with diabetes mellitus.
    Atallah MM; Daif AA; Saied MM; Sonbul ZM
    Br J Anaesth; 1992 Jun; 68(6):567-9. PubMed ID: 1610629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of fazadinium in children. An electromyographic study.
    Esener Z
    Br J Anaesth; 1983 Dec; 55(12):1205-12. PubMed ID: 6140023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of small incremental doses of d-tubocurarine on neuromuscular transmission in anesthetized man.
    Heisterkamp DV; Skovsted P; Cohen PJ
    Anesthesiology; 1969 May; 30(5):500-5. PubMed ID: 4305093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.